NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 87 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 205.18 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $266,000 | -28.5% | 417,835 | +2.9% | 0.00% | – |
| Q3 2016 | $372,000 | +72.2% | 405,907 | -0.2% | 0.00% | – |
| Q2 2016 | $216,000 | -94.0% | 406,720 | -89.4% | 0.00% | -100.0% |
| Q1 2016 | $3,608,000 | -32.6% | 3,820,282 | -5.2% | 0.00% | 0.0% |
| Q4 2015 | $5,357,000 | -40.0% | 4,028,112 | +2.9% | 0.00% | -50.0% |
| Q3 2015 | $8,929,000 | +40.7% | 3,916,029 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $6,347,000 | -5.1% | 3,942,167 | -6.3% | 0.00% | 0.0% |
| Q1 2015 | $6,689,000 | -14.2% | 4,206,922 | +2.0% | 0.00% | 0.0% |
| Q4 2014 | $7,795,000 | +67.6% | 4,124,161 | +17.0% | 0.00% | +100.0% |
| Q3 2014 | $4,651,000 | -14.8% | 3,523,555 | -4.5% | 0.00% | -50.0% |
| Q2 2014 | $5,459,000 | -12.5% | 3,688,518 | +9.4% | 0.00% | 0.0% |
| Q1 2014 | $6,239,000 | -6.9% | 3,372,427 | +4.2% | 0.00% | 0.0% |
| Q4 2013 | $6,700,000 | -25.3% | 3,236,654 | -4.4% | 0.00% | -33.3% |
| Q3 2013 | $8,970,000 | +12.1% | 3,384,828 | +12.9% | 0.00% | 0.0% |
| Q2 2013 | $8,003,000 | – | 2,997,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |